Health Blog

Tips | Recommendations | Reviews

How much is mavyret treatment cost off insurance?

how much is mavyret treatment cost off insurance
If you are concerned about the price of MAVYRET, you have choices. – * Cure is defined as no detectable hep C virus in the blood three months after therapy finishes. Individual outcomes might vary. As of January 2022, the advertised price, also known as the Wholesale Acquisition Cost (WAC), for one month of MAVYRET is $13,200.00.

If you have: You could pay:
$ 20
Medicaid $ 20 $20.00 or less per month, depending on state plan
Commercial Insurance (usually provided by employer) (Blue Cross Blue Shield, Aetna, etc) As little as $5 a month with MAVYRET Savings Card
Medicare: Part D $660.00-3,081.00 per month, depending on coverage phase Most Medicare patients have Standard Part D prescription coverage, which has different costs depending on deductibles and coverage gaps. An Insurance Specialist can help you understand what these costs mean to you, by calling 1-877-628-9738 . Monthly out-of-pocket cost for MAVYRET may vary depending on patient’s other medication costs.
Medicare: Low-Income Subsidy (LIS) $9.85 per month starting January 1, 2022
Uninsured or having difficulty paying for your medication myAbbVie Assist provides AbbVie medicines to qualifying patients. Visit or call 1-800-222-6885 to learn more.
Other Insurance (VA, DOD, TRICARE, others) Because coverage varies by plan, call 1-877-628-9738 to speak to an Insurance Specialist to find out how much MAVYRET will cost you.
*Important Details About Understanding Your Individual Costs: The chart above provides cost information based on what a person with the type of coverage listed may pay for a 4-week supply of MAVYRET. Your type of health or prescription insurance plan will determine exactly how much you will pay.

How much does the hepatitis C treatment cost?

Marsha Lecour developed hepatitis C when she was just four years old. She was born with a congenital cardiac defect that necessitated open-heart surgery. “During the operation, a blood transfusion was performed. In addition, the blood transfusion contained what is known as “tainted blood.” “Currently 65 years old and residing in Toronto, stated Lecour.

  • When she was in her 30s, decades later, a blood test revealed that she had a virus waging war on her liver.
  • The doctor told me I’d likely need a liver transplant,” she added.
  • I had never heard of hepatitis, let alone a liver transplant.
  • In situations like Lecour’s, Hepatitis C is typically transmitted by blood-to-blood contact, such as dangerous drug injections, incorrectly sterilized piercing, tattoo, or medical equipment, and contaminated blood.

People infected with the virus are frequently unaware of their infection. Some individuals are unaware until they have severe liver illness, such as cirrhosis or liver cancer. Most Canadians with hepatitis are unaware of their infection. Lecour lived with the condition for almost 50 years, attempting to reduce liver damage by diet, abstinence from alcohol, and meditation.

In 2012, her liver doctor at Toronto’s University Health Network put her on a “difficult” cocktail of medications to treat the condition. “In terms of side effects, some individuals compare it to chemotherapy,” Lecour added. “I lost a portion of my hair, I lost weight, and I was sad. I was a complete wreck.” Due to her lack of energy, Lecour was unable to perform her duties as a high school teacher during the treatment’s duration.

In the end, though, Lecour was cured of hepatitis C, and she reports that her life is “wonderful” now that she is free of the lethargy that the virus can cause and optimistic that the cirrhosis it caused is recovering. She does not know what she would have done if she had not had a “great” job benefit plan that covered the exorbitant price of the medications.

According to Andrew Hill, an infectious disease and pharmacology expert at the University of Liverpool in the United Kingdom, many of the 70 million individuals infected with hepatitis C confront the same problem as governments that pay prescription pharmaceuticals. In a presentation to the World Hepatitis Summit in Sao Paulo, Brazil, on Thursday, Andrew Hill, a researcher on drug accessibility, stated that the price of HIV/AIDS medications decreased to become more cheap, and the same should occur for the medication now known to cure hepatitis C.

“People are not receiving the therapy they require,” stated Andrew Hill. “Governments state, ‘This is too costly,’ and they do not treat everyone.” Thursday at the World Hepatitis Summit in Sao Paulo, Hill stated that 90% of hepatitis C patients may now be cured in 12 weeks at a cost of only $50 US per patient.

Moreover, the side effects are mild, therefore the majority of people would not experience what Lecour did. This treatment consists of the antiretroviral medicines Sofosbuvir and Daclatasvir. According to Hill’s study, the price paid by Canadian pharmaceutical makers for a 12-week treatment course is around $68,000 U.S.

According to his analysis, the price has soared to about $143,000 in the United States. Gilead Sciences, the maker of Sofosbuvir, and Bristol Myers Squibb, the manufacturer of Daclatasvir, were contacted by CBC News on their price, but no response was received as of Friday morning. Hepatitis C cure for under $300 US ignites enthusiasm “Some governments are too concerned about generating a significant cost to test a large number of individuals because they would have to pay tens of thousands of dollars to treat each of them. And they just do not have the necessary funds.” Many nations, including Canada, have pledged to eradicating hepatitis C by the year 2030.

How long is a Maviret course?

Maviret may be administered for 12 weeks to recipients of a liver or kidney transplant.